Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Management of status epilepticus in adults. Position paper of the Italian League against Epilepsy
Fabio Minicucci, Monica Ferlisi, Francesco Brigo, et al.
Epilepsy & Behavior (2019) Vol. 102, pp. 106675-106675
Closed Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Management of seizures in patients with primary mitochondrial diseases: consensus statement from the InterERNs Mitochondrial Working Group
Michelangelo Mancuso, Maria Papadopoulou, Yi Shiau Ng, et al.
European Journal of Neurology (2024) Vol. 31, Iss. 7
Open Access | Times Cited: 8
Insights into neurological dysfunction of critically ill COVID-19 patients
Cristian Deana, Lorenzo Verriello, Giada Pauletto, et al.
Trends in Anaesthesia and Critical Care (2020) Vol. 36, pp. 30-38
Open Access | Times Cited: 31
Clinical outcomes and treatments effectiveness in status epilepticus resolved by antiepileptic drugs: A five‐year observational study
Niccolò Orlandi, Giada Giovannini, Jessica Rossi, et al.
Epilepsia Open (2020) Vol. 5, Iss. 2, pp. 166-175
Open Access | Times Cited: 25
Vaginal candidiasis, predisposing factors, symptoms and treatment
Yurimare Radesca Moncayo
SCT Proceedings in Interdisciplinary Insights and Innovations. (2024) Vol. 2, pp. 347-347
Open Access | Times Cited: 3
Seizures, Epilepsy, and NORSE Secondary to Autoimmune Encephalitis: A Practical Guide for Clinicians
Alberto Vogrig, Gian Luigi Gigli, Annacarmen Nilo, et al.
Biomedicines (2022) Vol. 11, Iss. 1, pp. 44-44
Open Access | Times Cited: 13
Antiepileptic Drug Therapy for Status Epilepticus
Daeyoung Kim, Jae-Moon Kim, Yong Won Cho, et al.
Journal of Clinical Neurology (2021) Vol. 17, Iss. 1, pp. 11-11
Open Access | Times Cited: 17
Progression to refractory status epilepticus: A machine learning analysis by means of classification and regression tree analysis
Stefano Meletti, Giada Giovannini, Simona Lattanzi, et al.
Epilepsy & Behavior (2024) Vol. 161, pp. 110005-110005
Open Access | Times Cited: 2
A retrospective multicentric study on the effectiveness of intravenous brivaracetam in seizure clusters: Data from the Italian experience
Niccolò Orlandi, G. D’Orsi, Giada Pauletto, et al.
Seizure (2023) Vol. 108, pp. 72-80
Open Access | Times Cited: 6
Unmet needs of people with epilepsy: A qualitative study exploring their journey from presentation to long-term management across five European countries
Ella Graham-Rowe, Caroline Brigitte Katzer, Sumira Riaz, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 5
Machine learning validation through decision tree analysis of the Epidemiology‐Based Mortality Score in Status Epilepticus
Francesco Brigo, Gianni Turcato, Simona Lattanzi, et al.
Epilepsia (2022) Vol. 63, Iss. 10, pp. 2507-2518
Open Access | Times Cited: 9
Levetiracetam vs. phenytoin as 2nd-line treatment for status epilepticus: A systematic review and meta-analysis
Joshua M. DeMott, Giles W. Slocum, Michael Gottlieb, et al.
Epilepsy & Behavior (2020) Vol. 111, pp. 107286-107286
Closed Access | Times Cited: 12
Treatment of established status epilepticus in the elderly - a study protocol for a prospective multicenter double-blind comparative effectiveness trial (ToSEE)
Annekatrin Müller, Anett Schmiedeknecht, Meinhard Mende, et al.
BMC Neurology (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 11
Out‐of‐hospital versus in‐hospital status epilepticus: The role of etiology and comorbidities
Francesco Brigo, Gianni Turcato, Simona Lattanzi, et al.
European Journal of Neurology (2022) Vol. 29, Iss. 10, pp. 2885-2894
Open Access | Times Cited: 7
Treatment of benzodiazepine-refractory status epilepticus: A retrospective, cohort study
Eleonora Rollo, Marina Romozzi, Fedele Dono, et al.
Epilepsy & Behavior (2023) Vol. 140, pp. 109093-109093
Open Access | Times Cited: 4
Tendencia suicida asociada a Levetiracetam: una revisión sistemática
Daniel Alberto Polo Restrepo, Marcelo Adrián Estrín
SCT Proceedings in Interdisciplinary Insights and Innovations. (2024) Vol. 2, pp. 345-345
Open Access | Times Cited: 1
Recent Advances in Pathophysiology and Therapeutic Approaches in Epilepsy
Chandra Prakāsh, Pavan Kumar, Deepak Sharma
Brain Sciences (2024) Vol. 14, Iss. 8, pp. 785-785
Open Access | Times Cited: 1
Clinical characteristics and treatment approach of established New-Onset status epilepticus (eNOSE): A Real-World multicenter experience
Fedele Dono, Giacomo Evangelista, Davide Rodorigo, et al.
Epilepsy & Behavior (2024) Vol. 159, pp. 109951-109951
Open Access | Times Cited: 1
When is it time for palliative and end-of-life care in status epilepticus?
Reetta Kälviäinen, Zakarya Allal, Anne-Mari Kantanen
Epilepsy & Behavior (2023) Vol. 141, pp. 109058-109058
Open Access | Times Cited: 3
Predictive factors of Status Epilepticus and its recurrence in patients with adult–onset seizures: A multicenter, long follow–up cohort study
Sara Gasparini, Edoardo Ferlazzo, Gian Luigi Gigli, et al.
Seizure (2021) Vol. 91, pp. 397-401
Open Access | Times Cited: 7
Management of status epilepticus in patients with liver or kidney disease: a narrative review
Giovanni Mastroianni, Luigi Francesco Iannone, Roberta Roberti, et al.
Expert Review of Neurotherapeutics (2020) Vol. 21, Iss. 11, pp. 1251-1264
Closed Access | Times Cited: 6
A real-world pharmacovigilance study of severe cutaneous adverse reactions associated with antiepileptic drug combination therapy: data mining of FDA adverse event reporting system
Chunyan Wei, Jingyi Zhang, Wanhong Yin, et al.
Expert Opinion on Drug Safety (2022) Vol. 22, Iss. 6, pp. 509-515
Open Access | Times Cited: 4
Electrographic seizure duration and inter‐seizure intervals in focal status epilepticus
Stefano Meletti, Giulia Turchi, Niccolò Orlandi, et al.
Epileptic Disorders (2023) Vol. 25, Iss. 4, pp. 519-527
Open Access | Times Cited: 2
Efficacy of Perampanel in Refractory and Super-Refractory Status Epilepticus with Suspected Inflammatory Etiology: A Case Series
Annacarmen Nilo, Alberto Vogrig, Marco Belluzzo, et al.
Pharmaceuticals (2023) Vol. 17, Iss. 1, pp. 28-28
Open Access | Times Cited: 2
Development and Validation of a Nomogram Based on the Epidemiology-Based Mortality Score in Status Epilepticus (EMSE) Parameters to Predict 30-day Mortality in Status Epilepticus
Francesco Brigo, Gianni Turcato, Simona Lattanzi, et al.
Neurocritical Care (2022) Vol. 37, Iss. 3, pp. 754-760
Closed Access | Times Cited: 3
Retrospective External Validation of the Status Epilepticus Severity Score (STESS) to Predict In-hospital Mortality in Adults with Nonhypoxic Status Epilepticus: A Machine Learning Analysis
Francesco Brigo, Gianni Turcato, Simona Lattanzi, et al.
Neurocritical Care (2022) Vol. 38, Iss. 2, pp. 254-262
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top